Scrip Regulatory Affairs
FDA device chief defends US review process at govt hearing
22 February 2011
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Top journal editors question studies backing EU device regulation over US system
- Will PDUFA V be a 'damned if it does, damned if it doesn't' scenario for US FDA?
- Medtech industry gives nod to doubling of US FDA user fees in exchange for improved approval process - update
- US FDA action on drug shortages yields results, agency improves user fee goals
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
